Research Paper Volume 15, Issue 11 pp 5096—5124
Pan-cancer analysis of Homeobox B9 as a predictor for prognosis and immunotherapy in human tumors
Figure 4. Prognostic value of HOXB9 in pan-cancer. (A) Summary of the correlation between expression of HOXB9 with overall survival (OS), disease-specific survival (DSS), disease-free interval (DFI), and progression-free interval (PFI) based on the univariate Cox regression and Kaplan-Meier models. Red indicates that HOXB9 is a risk factor affecting the prognosis of cancer patients, and blue represents a protective factor. (B) The forest map exhibited the prognostic role of HOXB9 in OS in cancers by the univariate Cox regression method. (C) Kaplan-Meier curves comparing overall survival probability in GBM, KIRP, MESO, UVM, THYM, and UCEC cohorts with high and low HOXB9 expression.